# Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye

> **NCT03676335** · PHASE2 · COMPLETED · sponsor: **Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.** · enrollment: 240 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** CsA eye gel
- **DRUG:** CsA for eye emulsion
- **DRUG:** Hypromellose Eye Drops

## Key facts

- **NCT ID:** NCT03676335
- **Lead sponsor:** Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-09
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-12-12
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2020-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03676335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03676335, "Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03676335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*